Methylphenidate Hydrochloride Capsule, Extended Release
Product Images NDC 0093-5348

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Methylphenidate Hydrochloride (NDC 0093-5348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 1)

Chemical structure of Methylphenidate Hydrochloride, showing a phenyl ring attached to a carbon chain with a methyl ester and a piperidine ring, paired with hydrochloride (HCl).*

FDA Label Image

Figure 1 (Image 2)

A line graph comparing mean d-methylphenidate plasma levels (ng/mL) over time (hours) for Methylphenidate Hydrochloride Extended-Release 40 mg once daily and Methylphenidate 20 mg twice daily. The graph shows plasma concentration changes from 0 to 24 hours for both dosing regimens.*

FDA Label Image

Figure 2 (Image 3)

A bar chart comparing the mean final score minus mean baseline score between Methylphenidate Hydrochloride Extended-Release Capsules (n=63) and placebo (n=71). The chart includes error bars representing the standard error of the mean, showing a negative mean score for the Methylphenidate group and a positive mean score for the placebo group.*

FDA Label Image

0093-5346-01 20 mg 100s (Image 4)

Label for Methylphenidate Hydrochloride Extended-Release Capsules (LA) 20 mg, oral extended-release capsules. The label includes prescribing instructions, storage conditions, and manufacturer details for Teva Pharmaceuticals USA, Inc. The package size indicated is 100 capsules. A barcode and NDC number 0093-5346-01 are also visible.*

FDA Label Image

0093-5347-01 30 mg 100s (Image 5)

Label for Methylphenidate Hydrochloride Extended-Release Capsules (LA) 30 mg by Teva Pharmaceuticals USA, Inc. The capsule is indicated for oral, once-daily use and the label shows a 100 capsules package. It includes storage instructions, prescribing information reference, and a barcode with the NDC 0093-5347-01.*

FDA Label Image

0093-5348-01 40 mg 100s (Image 6)

Label for Methylphenidate Hydrochloride Extended-Release Capsules (LA), 40 mg, by Teva Pharmaceuticals USA, Inc. The label shows 100 capsules count, instructions for once-daily use, storage conditions, and a barcode. It specifies prescription use only and includes the NDC number 0093-5348-01.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.